The role of thalidomide as maintenance after autologous stem cell transplantation in multiple myeloma
Major progress was obtained over the last ten years in the treatment of multiple myeloma (MM). High dose chemotherapy with autologous stem cell transplantation (ASCT) and new drugs such as thalidomide, lenalidomide and bortezomib have completely changed the scenario of MM treatment. ASCT has become...
| Autor principal: | |
|---|---|
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2009
|
| Assuntos: | |
| Texto completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842009000800009 |
| País: | Brasil |
| Oai: | oai:scielo:S1516-84842009000800009 |